Verastem, Inc. (VSTM) stock

VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30

$8.18−0.26 (-3.08%)

Close on Nov 13, 2026Market cap $740.81MP/E –Yield –

Verastem gross margin

Gross margin is gross profit as a percentage of revenue.

Verastem's gross margin for the twelve months ending Dec 31, 2018 was 99.4%. For fiscal 2018 it was 99.4%.

Period	Period end	Value	Change (pts)
FY2018	Dec 31, 2018	99.4%	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2020	Sep 30, 2020	60.3%	–
Q1 FY2019	Mar 31, 2019	90.5%	–
Q4 FY2018	Dec 31, 2018	90.4%	–
Q3 FY2018	Sep 30, 2018	99.7%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is VSTM.

Operating margin-193.7% · median -140.0%

Net margin-178.4% · median -159.5%

Advertisement
300 × 250

See a number that looks wrong?